Exiqon has launched two new ProbeLibrary expression analysis kits,
covering the genomes of Arabidopsis thaliana and
Drosophila melanogaster, the most widely used models in
disease process and drug target studies.
RNA interference (RNAi) therapeutics to combat human illnesses such
as Huntingdon's disease, amyotrophic lateral sclerosis and
hepatitis C are set to fuel the rapid growth in the RNAi research
product market over the next year.
Researchers at the University of Rochester Medical Center, using GE
Healthcare's CodeLink microarrays, have identified key changes in
gene expression that provide an improved understanding of the
malfunction and death of the...
Key changes discovered in gene expression that provide an improved
understanding of neurones controlling movement and coordination and
their malfunction and death in Parkinson's Disease has lead to the
possibility of a drug therapy...
Switzerland's Lonza has negotiated exclusive rights to an
expression system, used in the manufacture of therapeutic proteins,
that could be used to shorten the development time for its
customers' biologic products.
A combination of a microarray technology developed by Switzerland's
Zeptosens and signal processing software from US firm ViaLogy has
provided a quantum leap in the sensitivity of gene expression
testing in a new study.
The market for non-array products used in the analysis of the
transcriptome - a map of gene expression and mRNA in the cell - is
maturing quickly but will still grow at more than 14 per cent a
year between 2003 and 2008, says a report...
A new approach to identifying patterns in gene expression analysis
has been shown to be more effective than the most popular method in
a joint Penn State and University at Buffalo study, write US
scientists this week.